Advicenne : June 15, 2021 - Advicenne provides an update on its activities following its Annual General Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Regulatory News: Advicenne (Euronext: ADVIC) (BSE:ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases
NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults
Aarhus, Denmark,
202
1 - NMD Pharma A/S, a biotech company developing novel therapeutics for neuromuscular disorders, today announces that it has initiated a pilot observational study to assess whether sarcopenia, a condition characterized by age-related loss of skeletal muscle mass and function, is associated with neuromuscular junction (NMJ) transmission deficits in older adults.
The US study will be led by Professor Brian Clark, PhD of Ohio University and Professor William David Arnold, MD, of The Ohio State University Wexner Medical Center and will involve 16 subjects: eight older sarcopenic individuals over the age of 70 and eight healthy young and middle aged individuals between the ages of 18 and 50. Subjects will undergo electrophysiological testing (repetitive nerve stimulation and single fibre electromyography (EMG) analyses) and diffe
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board
Indigo Diabetes N.V.May 12, 2021 GMT
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board
Brings decades of leadership experience in the Global MedTech sector
As CEO of ConvaTec Group Plc,
led the $
Transformed Abbott’s Diabetes Care EMEA division
BELGIUM - Ghent, May 12, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, is pleased to announce the appointment of Paul Moraviec as Chairman of its Board of Directors.
Indigo Diabetes N.V.: Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board
Brings decades of leadership experience in the Global MedTech sector
As CEO of ConvaTec Group Plc,
led the $
Transformed Abbott s Diabetes Care EMEA division
BELGIUM - Ghent, May
2
, 2021 - Indigo Diabetes N.V. ( Indigo or the Company ), a pioneering developer of medical solutions using nanophotonics, is pleased to announce the appointment of Paul Moraviec as Chairman of its Board of Directors.
Paul has amassed over three decades of global experience in the healthcare sector, having held multiple senior leadership positions. Most recently Paul led the ConvaTec Group Plc, a global medical products and technologies company, as Chief Executive Officer, orchestrating a successful company turnaround and subsequent $4.5 billion IPO on the London Stock Exchange in 2016, which at the time was the largest healthcare listing in Europe.